Login

PRRT therapy: interpreting published trial outcomes

A guide to the endpoints used in PRRT research and the records needed for an individual treatment discussion.

Editorial update: 3 November 2026. The study references below describe published research, not TPPL-specific outcome rates.

Which result is being described?

Tumour shrinkage, symptom control and progression-free survival answer different questions. A service should not turn one of these endpoints into a blanket cure or success promise.

NETTER-1 in context

NETTER-1 evaluated Lu-177 DOTATATE in a defined group with progressive, somatostatin-receptor-positive midgut neuroendocrine tumours. The study reported improved progression-free survival compared with its control regimen. It does not establish an identical outcome for every neuroendocrine tumour, grade or treatment line.

What the team needs

Provide pathology and grade, receptor-imaging results, previous treatments and current blood/organ-function results. The treating specialists decide whether PRRT and the published evidence fit the patient's circumstances.

Cost and planning

Ask for the proposed cycles and an itemised quote rather than inferring a total from one study. PRRT therapy and cost information.

Questions to discuss with the treating team

Does PRRT work the same way for every NET?

No. Tumour type, receptor expression, grade, previous treatments and safety assessment all affect the discussion.

Can the clinic promise the trial result for me?

No. Published trial endpoints describe groups and do not guarantee an individual result.

Published references

Medical disclaimer All physicians and researchers profiled on this page hold appointments in the Department of Nuclear Medicine & Molecular Imaging, Sector 44, Gurugram. Theranostic Physicians Private Limited (TPPL) is the clinical practice entity through which they consult and treat patients. Treatment outcomes vary by individual case; clinical decisions are made on the basis of complete medical records, current imaging, and a multidisciplinary review.